BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15582162)

  • 1. Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1.
    Vercauteren FG; Clerens S; Roy L; Hamel N; Arckens L; Vandesande F; Alhonen L; Janne J; Szyf M; Cuello AC
    Brain Res Mol Brain Res; 2004 Dec; 132(2):241-59. PubMed ID: 15582162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
    J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
    Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations.
    Sudo S; Shiozawa M; Cairns NJ; Wada Y
    J Neurol Sci; 2005 Jul; 234(1-2):55-65. PubMed ID: 15946688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1.
    Jankowsky JL; Slunt HH; Gonzales V; Jenkins NA; Copeland NG; Borchelt DR
    Neurobiol Aging; 2004 Aug; 25(7):885-92. PubMed ID: 15212842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1.
    Szapacs ME; Numis AL; Andrews AM
    Neurobiol Dis; 2004 Aug; 16(3):572-80. PubMed ID: 15262269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
    Miettinen R; Riedel A; Kalesnykas G; Kettunen HP; Puoliväli J; Soininen H; Arendt T
    J Chem Neuroanat; 2005 Oct; 30(2-3):105-18. PubMed ID: 16081247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
    Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presenilin 1 binds to amyloid precursor protein directly.
    Waragai M; Imafuku I; Takeuchi S; Kanazawa I; Oyama F; Udagawa Y; Kawabata M; Okazawa H
    Biochem Biophys Res Commun; 1997 Oct; 239(2):480-2. PubMed ID: 9344855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Wirths O; Weis J; Szczygielski J; Multhaup G; Bayer TA
    Acta Neuropathol; 2006 Apr; 111(4):312-9. PubMed ID: 16520967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation.
    Folkesson R; Malkiewicz K; Kloskowska E; Nilsson T; Popova E; Bogdanovic N; Ganten U; Ganten D; Bader M; Winblad B; Benedikz E
    Biochem Biophys Res Commun; 2007 Jul; 358(3):777-82. PubMed ID: 17506994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
    Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice.
    Puoliväli J; Wang J; Heikkinen T; Heikkilä M; Tapiola T; van Groen T; Tanila H
    Neurobiol Dis; 2002 Apr; 9(3):339-47. PubMed ID: 11950278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.